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Abstract
We describe a 23-year-old DF508 homozygote cystic fibrosis primigravida. At the onset of gestation, she had mild to moderate
pulmonary involvement, exocrine pancreatic insufficiency, focal biliary cirrhosis, satisfactory nutritional status and normal fasting
and post-prandial glucose blood levels. At 29 weeks, she developed polyhydramnion and gestational diabetes. At 37 weeks, she
was delivered of a live 2980 g boy by caesarean section under epidural anaesthesia. Insulin was subsequently discontinued and
her pulmonary function improved spontaneously. Neither maternal nor neonatal health problems were observed during the 3-
month follow-up.  2002 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Despite reduced fertility, pregnancy is achieved with
increasing frequency in female patients with cystic
fibrosis (CF) w1x. It has been reported that pregnancy
can be tolerated well by the majority of CF females w2x.
The clinical outcome of the CF patient during pregnancy
is predominantly related to the pre-pregnancy pulmonary
status wforced expiratory volume in 1 s (FEV ), forcedabc 1
vital capacity (FVC)x w2–4x. Other factors which may
affect the clinical course of the CF patient during
pregnancy are nutrition, diabetes mellitus, the presence
of Burkholderia cepacia and frequent respiratory exac-
erbations w2x. Pregnancy in CF patients is associated
with premature delivery (9–35%) w2,5x and other com-
plications such as diabetes mellitus, which increases the
risk of prematurity, foetal complications and maternal
morbidity w6x.
We report a case of pregnancy in a young female
patient with CF having mild to moderate pulmonary
disease who developed polyhydramnion and diabetes
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mellitus during pregnancy. Despite these complications
she was delivered of a perfectly healthy boy at 37 weeks
of gestation by caesarean section.
2. Case report
We describe a 23-year-old primigravida having cystic
fibrosis (DF508yDF508). Although chronically infected
with Pseudomonas aeroginosa she had mild lung disease
(FEV 82% pred.). Additionally she had exocrine pan-1
creatic insufficiency and focal biliary cirrhosis. Her
nutritional status was satisfactory with a body mass
index (BMI) of 20 kgym .2
Treatment consisted of pancreatic enzymes (Creon
25 000 IUyper meal), liposoluble vitamins (Centrum, 1
tablet twice daily), ursodeoxycholic acid (Ursofalk, 20
mgykg per day) and rhDNase (Pulmozyme ) by
inhalation.
Her pregnancy occurred without planning or counsel-
ling. Genetic evaluation of her husband for the 10 CF
mutations most common in Greece was negative. Ultra-
sound examination at 29 gestational weeks showed the
presence of polyhydramnion. An oral glucose tolerance
test demonstrated gestational diabetes. Consequently, she
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Table 1
Pre-pregnancy, pregnancy and post-partum clinical status
Pre-pregnancy Pregnancy Post-partum
10 days 3 months
FEV (%)1 82 78 76 72 80 82
FVC (%) 76 70 68 66 72 74
Brasfield score 20 – 20 –
Schwachman– 90 – 97 –
Kulczycki score
received insulin subcutaneously (mixed regular and
intermediate insulin) twice daily until delivery. Addi-
tionally she received dexamethasone (12 mgyday) and
indomethacin (1000 mgyday) for 3weeks to treat poly-
hydramnion. Her daily nutritional intake consisted of
3500 kcal (50% carbohydrate, 35% fat, 15% protein)
divided into three main meals and three snacks. During
pregnancy a weight gain of 14 kg was noted. Over time,
her pulmonary function deteriorated slightly (Table 1)
but no infectious pulmonary exacerbations occurred.
Ursodeoxycholic acid was discontinued during the first
trimester of gestation without deterioration of laboratory
liver function tests or ultrasound examination.
Because of diabetes mellitus, a caesarean section was
performed under epidural anaesthesia at 37 weeks of
gestation. A perfectly healthy boy (2980 g) was deliv-
ered. No perinatal problems were encountered. The
newborn did not show hypoglycaemia or hypoglycaemic
seizures during the early neonatal period. Obstetric
complications did not occur. The mother developed
hypoglycaemic episodes so that the exogenous insulin
was gradually discontinued. Post-partum FEV and FVC1
improved spontaneously to pre-pregnancy values (Table
1).
The infant was DF508 heterozygote. At the 3-month
follow-up, both mother and infant were in good health.
The infant had doubled his birth weight.
3. Discussion
We describe a 23-year-old CF primigravida with mild
pulmonary disease, well controlled exocrine pancreatic
insufficiency and early hepatic involvement. Following
severe polyhydramnion during pregnancy she developed
diabetes mellitus for which she received insulin. Addi-
tionally her lung function deteriorated. Her pregnancy
ended successfully with the delivery of a live healthy
boy. After delivery her lung function normalised to pre-
pregnancy values.
Puberty and the establishment of regular menstruation
are often delayed in CF women. Furthermore, secondary
amenorrhoea maybe due to undernutrition w6–8x. Subfer-
tility maybe due to abnormal cervical mucus viscosity
or anovulatory cycles w6–8x. The improved life expec-
tancy in CF has led to increased frequency of pregnancy
and motherhood in CF female patients despite this
reduced fertility. The patient described in this case report
did not have any puberty, menstrual or infertility
problems.
She developed gestational diabetes mellitus at 29
weeks of gestation. The prevalence of gestational dia-
betes in pregnant women with CF is higher than that in
the general population (14%) w2,9x. Therefore, screening
for diabetes is recommended at 20 weeks of gestation
w10x.
Premature delivery is frequently associated with preg-
nancy in CF (9–35%) w2,5x. Female patients with CF
and impaired lung function, decreased body weight, and
complications, such as cor pulmonale and diabetes
mellitus, have a higher risk of prematurity, foetal com-
plications and maternal morbidity w1,11x. Pre-pregnancy
FEV less than 60% of the predicted value also results1
in a substantial risk of premature delivery, increased rate
of caesarean section, some loss of lung function, a risk
of respiratory complications and early maternal death
w3x. Kent et al. w12x reported a cohort of 217 pregnancies
in 162 women in which spontaneous abortion occurred
in 10 (4.6%). Pregnancy progressed beyond 20 weeks
in 81.6% of cases and 24.3% of the deliveries were pre-
term. The maternal death rate did not exceed that among
age-related women with CF who were not pregnant w12x.
The rate of perinatal death was 7.9%. According to the
same report w12x poor outcome is associated with a
weight gain of less than 4.5 kg and a FVC of less than
50% of predicted values. In the patient described in this
article, the infant was born at 37 weeks by caesarean
section as decided by the obstetrician.
Prognosis of pregnancy depends mainly on pulmonary
function. Repeated lung infections and chronic infection
with Burkholderia cepacia are factors consistent with
poor prognosis w2x. Pre-pregnancy FEV appears to be1
the most useful criterion for outcome and counselling
w2–4,12x. The outcome of the patient in this case after
pregnancy was excellent. This was compatible with her
mild to moderate pulmonary disease and her satisfactory
clinical status.
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